|

chemotherapy + PD-1 inhibitors Clinical Trials

1 actively recruiting trial

Also known as: Radiotherapy

Pipeline

Phase 2: 1

Top Sponsors

  • Xinqiao Hospital of Chongqing1

Indications

  • NSCLC Stage IV Without EGFR/ALK Mutation1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.